Develops drugs for Wilson disease and cancer.
Dec 2025Revenue $0.00/yrExpenses $16.7M/yr
No trendCash runway ≈ 8.6 years from Jun 2026
Figures by year
When will Monopar Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $16.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $16.7M | −$16.7M |
| Dec 2024 | $0.00 | $16.2M | −$16.2M |
| Dec 2019 | $0.00 | $4.32M | −$4.32M |
| Dec 2018 | $0.00 | $3.33M | −$3.33M |
| Dec 2017 | $0.00 | $16.6M | −$16.6M |
| Dec 2016 | $0.00 | $1.19M | −$1.19M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.